Amazon eyeing Japan prescription drug market, says Nikkei
Bet_Noire/iStock via Getty Images


The Nikkei newspaper reported on Monday that Amazon (NASDAQ:AMZN) is looking to enter the prescription drug sales market in Japan.
Citing people involved in the project, Nikkei said that the e-commerce giant is considering partnering with small- and mid-sized pharmacies for the service, starting next year when electronic prescriptions are allowed for the first time in the Asian country.

Last Friday, Bloomberg reported that Amazon (AMZN) pulled back on plans for dozens of facilities across the U.S. as it appeared to be adjusting to growth expectations.
This is in contrast to a recent Bank of America report which stated that Amazon's (AMZN) e-commerce growth rates picked up in Q3.